scPharmaceuticals Inc. Prices 6.4M Share IPO at $14/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
November 16, 2017 9:05 PM ESTBURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the Company) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs, today announced the pricing of its initial public offering of 6,400,000 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts and commissions, for gross proceeds of $89.6 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public offering price, less the underwriting... More
